PDA

View Full Version : Diabete's and the USA Medical for a PPL


JB007
15th Dec 2000, 00:01
Looking for info on USA diabete's restrictions for the FAA PPL.
Anyone know ?
Or a FAA AME in the Uk I can call.

Cheers
007


------------------
Hear All...See All...Say Now't.

inverted flatspin
15th Dec 2000, 08:17
Hi I copied this info from the AOPA medical info site. It is only available to AOPA members but here it is

Diabetes Specifications
Initial and Follow-up
Pilots with a diagnosis of diabetes mellitus controlled by diet alone are considered eligible for medical certification under the revised Part 67 medical standards. Medical documentation as described below is required at the time of examination. The aviation medical examiner may issue a certificate to applicants with this history, provided the necessary documentation is provided, and they are otherwise qualified. Applicants who report using oral medications may not be issued a certificate by the aviation medical examiner. After initial clearance, the FAA may authorize the examiner to issue future certificates, as long as there are no significant adverse changes noted on the follow up reports.

Applicants who are controlling diabetes by diet or with oral medications, including glucophage (metformin), or precose (acarbose) will be expected to demonstrate for 60 days evidence of adequate control, stabilization, and no evidence of adverse side effects or complications from medication.

After the 60 day control period is completed, and within the next 30 days, a glycosolated hemoglobin (A1C) should be done. Normal laboratory values for A1C hemoglobin will range from about 4.0%-7.5%. The FAA will allow up to 9%.

There should also be no evidence of significant medical or surgical complications, including cardiac, peripheral vascular, renal, neurological, or ophthalmologic disease.

No beta-adrenergic blocking antihypertensive agents should be used. These medications may increase blood glucose.
Minimum requirements for follow up evaluation will vary with the class of medical certificate held. 1st and 2nd Class certificate holders will usually be required to submit follow up evaluations annually. 3rd Class holders will submit evaluations at the time of their regular FAA medical renewal. Individual cases may require more frequent evaluations based on case history.

Note: Express mail will usually expedite the delivery of your records to the FAA. If you choose to use overnight delivery, the correct address is:


Federal Aviation Administration
Aeromedical Certification Division
CAMI Building Room B59
6700 S. MacArthur Blvd.
Oklahoma City, OK 73126

Phone 405-954-4821

--------------------------------------------------------------------------------

inverted flatspin
15th Dec 2000, 08:21
Here is some more info. Hope it helps.

Aeromedical Certification of Individuals with Insulin-Treated Diabetes Mellitus
The FAA is now considering certification, under the Special Issuance provisions of the Federal Aviation Regulations, of some individuals with insulin-treated diabetes mellitus (ITDM). The following restrictions apply:

ITDM individuals:

may be issued only a third-class medical certificate;
may exercise only the privileges of a student, recreational, or private pilot certificate;
are prohibited from operating an aircraft as a required crew member on any flight outside the airspace of the United States of America;
are required to be in compliance with the monitoring requirements of the protocol outlined below while exercising the privileges of a third-class medical certificate.
In order to be considered for aeromedical certification, an individual with ITDM should have been receiving appropriate insulin treatment for at least 6 months prior to submitting a request for medical certification. Consideration will be given to individuals using a combination insulin/oral medication regimen, however, Rezulin is not currently considered an acceptable oral agent for combination use. Additionally, the following criteria must also be met:

For initial certification:

Applicants must have no otherwise disqualifying conditions, especially significant diabetes-related complications such as arteriosclerotic coronary or cerebral disease, retinal disease, or chronic renal failure, and must have had no recurrent (two or more) hypoglycemic reactions within the past 5 years:
that resulted in a loss of consciousness or seizure;
that required intervention by another party;
or that resulted in impaired cognitive function which occurred without warning symptoms.
A period of 1 year of demonstrated stability is required following the first episode of hypoglycemia.
In order to provide an adequate basis for an individual medical determination, the applicant seeking special issuance of a medical certificate must submit the following:
Copies of all medical records concerning the individual's diabetes diagnosis and disease history and copies of all hospital records, if admitted for any diabetes-related cause, including accidents and injuries;
Copies of complete records of any incidents or accidents, particularly involving moving vehicles, whether or not the event resulted in injury or property damage, if due in part or totally to diabetes complications;
Results of a complete medical evaluation by an endocrinologist or other diabetes specialist. This report should detail the individual's complete medical history and current medical condition. The report must include a general physical examination and the following:
Two measurements of glycated hemoglobin (total A1 or A1C concentration and the laboratory reference normal range), the first at least 90 days prior to the second measurement;
(b) A detailed report of the individual's insulin dosages (including types) and diet utilized for glucose control;
Appropriate examinations and tests to detect any peripheral neuropathy or circulatory compromise of the extremities and any other tests deemed necessary by the treating specialist, or that are clinically indicated; and
Confirmation by an ophthalmologist of the absence of clinically significant eye disease. The eye examination should assess visual acuity, ocular hypertension, and presence of lenticular opacities, if any, and include an examination of the retina for evidence of any diabetic retinopathy or macular edema. Individuals with active retinopathy or vitreous hemorrhages will not be considered until the condition has been confirmed as stabilized by an ophthalmologist.
If the applicant is age 40 or older, a report of a maximal graded exercise stress test, including ECG tracings.
The applicant shall submit a statement from his/her treating physician, aviation medical examiner, or other knowledgeable person attesting to the applicant's dexterity and ability to determine blood glucose levels using a recording glucometer.
Verification that the individual has been educated in diabetes and its control and has been thoroughly informed of and understands the monitoring and management procedures for the condition and the actions that should be followed if complications of diabetes, including hypoglycemia, should arise. The examining physician should also verify that the applicant has the ability and willingness to properly monitor and manage his or her diabetes.
The individual must agree to immediately report any adverse medical changes to the FAA.
Applicants shall maintain appropriate medical supplies for glucose management while preparing for flight and while exercising piloting privileges. Such supplies shall include:
a whole blood digital glucose monitor with memory;
supplies needed to obtain blood samples and to measure whole blood glucose; and
an amount of rapidly absorbable glucose, in 10 gram (gm) portions, appropriate for the planned duration of the flight.
All disposable supplies listed above must be within their expiration dates.
Preflight:

Not more than ½ hour before takeoff, the pilot shall establish and document a blood glucose concentration equal to or greater than 100 milligrams/deciliter (mg/dl) but not greater than 300 mg/dl. If the concentration is within 100-300 mg/dl, flight operations may commence. If less than 100 mg/dl, an appropriate glucose snack (at least 10 gm.) must be ingested and a recheck done. If over 300 mg/dl, the flight must be postponed.

Inflight:

One hour into the flight, at subsequent hourly intervals, and within one half hour of landing, the pilot shall monitor the blood glucose concentration. If the concentration is less than 100 mg/dl, a 20 gm snack shall be ingested. If the concentration is between 100-300 mg/dl, no action is required. If the concentration is greater than 300 mg/dl, the pilot must land at the nearest suitable airport and may not resume flight until the glucose concentration can be maintained in the 100-300 mg/dl range.

With respect to determining blood glucose determinations in flight, the airman must use good judgment in deciding whether measuring concentrations or operational demands of the flight environment, such as adverse weather, air traffic control concerns, or engine trouble should take priority. In cases where operational considerations take priority, the airman should ingest a 10 gm glucose snack, fly the airplane, and measure blood glucose concentrations one hour later. If measurement is not practicable at that time, the airman must ingest a 20 gm glucose snack and land at the nearest suitable airport until a determination of the blood glucose concentration can be made.

For subsequent recertification:

Individuals who are granted special issuance of third-class airman medical certificates must:

Submit to a medical evaluation by a specialist every 3 months. This evaluation must include a general physical examination, a review of the interval medical history, and a report of glycated hemoglobin (total A1 or A1C) concentrations and any other tests deemed necessary by the treating specialist or that are clinically indicated. Also, the examining physician must review the record of the airman's daily blood glucose measurements and comment on the results. The evaluation shall also contain an assessment of the individual's continued ability and willingness to monitor and properly manage his or her diabetes and whether the diabetes or its complications could reasonably be expected to adversely affect the airman's ability to safely control an aircraft.

Provide to the FAA, immediately upon request, a report by a specialist or other physician, of any evidence of loss of diabetes control, significant complications, or inability to manage the diabetes. In such a case, the individual shall cease exercising the privileges of his or her airman certificate until again medically cleared by the FAA.


--------------------------------------------------------------------------------
Updated by AOPA Medical Certification: 11/99
--------------------------------------------------------------------------------
Top
Updated Tuesday, November 02, 1999 9:01:13 AM

--------------------------------------------------------------------------------

JB007
16th Dec 2000, 23:49
IF,

This is fantastic...thanks very much.

Cheers
007

------------------
Hear All...See All...Say Now't.